ASPHF
Price
$9.32
Change
-$0.78 (-7.72%)
Updated
Sep 17 closing price
Capitalization
3.56B
CGEN
Price
$1.40
Change
+$0.02 (+1.45%)
Updated
Sep 26, 01:36 PM (EDT)
Capitalization
130.64M
41 days until earnings call
Interact to see
Advertisement

ASPHF vs CGEN

Header iconASPHF vs CGEN Comparison
Open Charts ASPHF vs CGENBanner chart's image
ASCENTAGE PHARMA GROUP
Price$9.32
Change-$0.78 (-7.72%)
Volume$3.2K
Capitalization3.56B
Compugen
Price$1.40
Change+$0.02 (+1.45%)
Volume$14.73K
Capitalization130.64M
ASPHF vs CGEN Comparison Chart in %
Loading...
ASPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASPHF vs. CGEN commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPHF is a Hold and CGEN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ASPHF: $9.32 vs. CGEN: $1.38)
Brand notoriety: ASPHF and CGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASPHF: 205% vs. CGEN: 53%
Market capitalization -- ASPHF: $3.56B vs. CGEN: $130.64M
ASPHF [@Biotechnology] is valued at $3.56B. CGEN’s [@Biotechnology] market capitalization is $130.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASPHF’s FA Score shows that 0 FA rating(s) are green whileCGEN’s FA Score has 1 green FA rating(s).

  • ASPHF’s FA Score: 0 green, 5 red.
  • CGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ASPHF and CGEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASPHF’s TA Score shows that 2 TA indicator(s) are bullish while CGEN’s TA Score has 4 bullish TA indicator(s).

  • ASPHF’s TA Score: 2 bullish, 3 bearish.
  • CGEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CGEN is a better buy in the short-term than ASPHF.

Price Growth

ASPHF (@Biotechnology) experienced а 0.00% price change this week, while CGEN (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

CGEN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASPHF($3.56B) has a higher market cap than CGEN($131M). ASPHF YTD gains are higher at: 246.468 vs. CGEN (-9.804). CGEN has higher annual earnings (EBITDA): -19.81M vs. ASPHF (-1.09B). ASPHF has more cash in the bank: 1.66B vs. CGEN (93.9M). CGEN has less debt than ASPHF: CGEN (2.97M) vs ASPHF (1.72B). ASPHF has higher revenues than CGEN: ASPHF (391M) vs CGEN (22.1M).
ASPHFCGENASPHF / CGEN
Capitalization3.56B131M2,720%
EBITDA-1.09B-19.81M5,478%
Gain YTD246.468-9.804-2,514%
P/E RatioN/A64.00-
Revenue391M22.1M1,769%
Total Cash1.66B93.9M1,769%
Total Debt1.72B2.97M57,778%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASPHFCGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
20%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
30%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
29%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
17%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
11%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
33%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
25%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ASPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRIBF74.00N/A
N/A
Horiba Ltd.
PEBC63.00N/A
N/A
Peoples Bancorp Inc.
SBHMY20.16N/A
N/A
Sino Biopharmaceutical Ltd.
RENI0.06N/A
N/A
Resilient Energy Inc.
BORUF4.27-0.17
-3.83%
Borussia Dortmund GMBH & Co.

ASPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with CGEN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASPHF
1D Price
Change %
ASPHF100%
N/A
CGEN - ASPHF
41%
Loosely correlated
-1.43%
CLLS - ASPHF
34%
Loosely correlated
-4.32%
CMVLF - ASPHF
34%
Loosely correlated
N/A
NURPF - ASPHF
30%
Poorly correlated
N/A
ALDX - ASPHF
27%
Poorly correlated
-1.20%
More